Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00227_DB00564_nanopub.RAhL_U0W0RE9ea5jMH0zThPJtbnMSZC4jEbTsL6GZUUQc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00227_DB00564 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00227_DB00564 label "DDI between Lovastatin and Carbamazepine - Carbamazepine, a p-glycoprotein inducer and strong CYP3A4 inducer, may decrease the effect of lovastatin by increasing its efflux and metabolism. Monitor for changes in the therapeutic and adverse effects of lovastatin if carbamazepine is initiated, discontinued or dose changed. [drugbank_resource:DB00227_DB00564]" assertion.
- drugbank_resource:DB00227_DB00564 identifier "drugbank_resource:DB00227_DB00564" assertion.
- drugbank_resource:DB00227_DB00564 title "DDI between Lovastatin and Carbamazepine - Carbamazepine, a p-glycoprotein inducer and strong CYP3A4 inducer, may decrease the effect of lovastatin by increasing its efflux and metabolism. Monitor for changes in the therapeutic and adverse effects of lovastatin if carbamazepine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00564 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00227_DB00564 assertion.
- drugbank:DB00227 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00227_DB00564 assertion.